摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

亚丁基二醇丙酸盐 | 90155-19-4

中文名称
亚丁基二醇丙酸盐
中文别名
克霉唑-氢化可的松
英文名称
Canesten HC
英文别名
1-[(2-chlorophenyl)-diphenylmethyl]imidazole;(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
亚丁基二醇丙酸盐化学式
CAS
90155-19-4
化学式
C43H47ClN2O5
mdl
——
分子量
707.3
InChiKey
MFXYQIHPQYSOHM-WPUDDCNKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.16
  • 重原子数:
    51
  • 可旋转键数:
    6
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    113
  • 氢给体数:
    3
  • 氢受体数:
    6

文献信息

  • Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
    申请人:FERRER INTERNACIONAL, S.A.
    公开号:EP1698336A1
    公开(公告)日:2006-09-06
    Pharmaceutical compositions useful for treating dermal diseases caused by fungi and yeasts with inflammation and/or associated with a bacterial infection. Such compositions contain a therapeutically effective amount of Sertaconazole, or a pharmaceutically acceptable salt, solvate, isomer thereof or mixtures thereof; and a therapeutically effective amount of at least one compound selected from the group consisting of Hydrocortisone, a pharmaceutically acceptable ester of Hydrocortisone, an antibacterial agent or mixtures thereof.
    用于治疗真菌和酵母菌引起的皮肤疾病、炎症和/或与细菌感染有关的疾病的药物组合物。此类组合物含有治疗有效量的舍他康唑或其药学上可接受的盐、溶解物、异构体或其混合物;以及治疗有效量的至少一种选自氢可的松、氢可的松药学上可接受的酯、抗菌剂或其混合物的化合物。
  • ANTIFUNGAL COMPOSITIONS COMPRISING SERTACONAZOL AND HYDROCORTISONE AND/OR AN ANTIBACTERIAL QUINOLONE COMPOUND
    申请人:FERRER INTERNACIONAL, S.A.
    公开号:EP1858510A1
    公开(公告)日:2007-11-28
  • Antifungal Compositions
    申请人:Palacin Celia
    公开号:US20080166398A1
    公开(公告)日:2008-07-10
    Pharmaceutical compositions useful for treating dermal diseases caused by fungi and yeasts with inflammation and/or associated with a bacterial infection. Such compositions contain a therapeutically effective amount of sertaconazole, or a pharmaceutically acceptable salt, solvate, isomer thereof or mixtures thereof; and a therapeutically effective amount of at least one compound selected from the group consisting of hydrocortisone, a pharmaceutically acceptable ester of hydrocortisone, an antibacterial quinolone compound, and mixtures thereof.
  • [EN] ANTIFUNGAL COMPOSITIONS COMPRISING SERTACONAZOL AND HYDROCORTISONE AND/OR AN ANTIBACTERIAL QUINOLONE COMPOUND<br/>[FR] COMPOSITIONS ANTIFONGIQUES CONTENANT DE LA SERTACONAZOLE ET DE L'HYDROCORTISONE ET/OU UN COMPOSE DE QUINOLONE ANTIBACTERIEN
    申请人:FERRER INT
    公开号:WO2006092374A1
    公开(公告)日:2006-09-08
    [EN] Pharmaceutical compositions useful for treating dermal diseases caused by fungi and yeasts with inflammation and/or associated with a bacterial infection. Such compositions contain a therapeutically effective amount of sertaconazole, or a pharmaceutically acceptable salt, solvate, isomer thereof or mixtures thereof; and a therapeutically effective amount of at least one compound selected from the group consisting of hydrocortisone, a pharmaceutically acceptable ester of hydrocortisone, an antibacterial quinolone compound, and mixtures thereof.
    [FR] L'invention concerne des compositions pharmaceutiques utiles dans le traitement de maladies dermiques provoquées par des champignons et des levures, présentant une inflammation et/ou associées à une infection bactérienne. Ces compositions contiennent une quantité thérapeutiquement efficace de sertaconazole, ou un sel pharmaceutiquement acceptable, un solvant ou un isomère de celui-ci ; ainsi qu'une quantité thérapeutiquement efficace d'au moins un composé choisi dans le groupe hydrocortisone, un sel pharmaceutiquement acceptable d'hydrocortisone, un composé de quinolone antibactérien, et des mélanges de ceux-ci.
  • [EN] A SYSTEM FOR THE TREATMENT OF DERMATOLOGICAL INFECTIONS<br/>[FR] SYSTÈME POUR LE TRAITEMENT D'INFECTIONS DERMATOLOGIQUES
    申请人:SOL-GEL TECH LTD
    公开号:WO2016142946A1
    公开(公告)日:2016-09-15
    The present invention provides a system comprising econazole and mometasone, including uses and methods of treatment of dermatological infectious diseases, disorders and symptoms thereof.
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B